These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 29308325)

  • 1. Eosinophils: The unsung heroes in cancer?
    Varricchi G; Galdiero MR; Loffredo S; Lucarini V; Marone G; Mattei F; Marone G; Schiavoni G
    Oncoimmunology; 2018; 7(2):e1393134. PubMed ID: 29308325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Mast Cells MASTers in Cancer?
    Varricchi G; Galdiero MR; Loffredo S; Marone G; Iannone R; Marone G; Granata F
    Front Immunol; 2017; 8():424. PubMed ID: 28446910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsung heroes in the battle against cancer.
    Kaul P; Garg PK
    Palliat Support Care; 2023 Oct; 21(5):961-962. PubMed ID: 37503564
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulocytes: New Members of the Antigen-Presenting Cell Family.
    Lin A; Loré K
    Front Immunol; 2017; 8():1781. PubMed ID: 29321780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells, basophils and eosinophils: From allergy to cancer.
    Rigoni A; Colombo MP; Pucillo C
    Semin Immunol; 2018 Feb; 35():29-34. PubMed ID: 29428698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.
    Hollande C; Boussier J; Ziai J; Nozawa T; Bondet V; Phung W; Lu B; Duffy D; Paradis V; Mallet V; Eberl G; Sandoval W; Schartner JM; Pol S; Barreira da Silva R; Albert ML
    Nat Immunol; 2019 Mar; 20(3):257-264. PubMed ID: 30778250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood eosinophil count in the general population: typical values and potential confounders.
    Hartl S; Breyer MK; Burghuber OC; Ofenheimer A; Schrott A; Urban MH; Agusti A; Studnicka M; Wouters EFM; Breyer-Kohansal R
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32060069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new dawn for eosinophils in the tumour microenvironment.
    Grisaru-Tal S; Itan M; Klion AD; Munitz A
    Nat Rev Cancer; 2020 Oct; 20(10):594-607. PubMed ID: 32678342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial.
    Busse WW; Bleecker ER; FitzGerald JM; Ferguson GT; Barker P; Sproule S; Olsson RF; Martin UJ; Goldman M;
    Lancet Respir Med; 2019 Jan; 7(1):46-59. PubMed ID: 30416083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophils: Friends or Foes?
    Chusid MJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1439-1444. PubMed ID: 30197067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma exacerbations on benralizumab are largely non-eosinophilic.
    Poznanski SM; Mukherjee M; Zhao N; Huang C; Radford K; Ashkar AA; Nair P
    Allergy; 2021 Jan; 76(1):375-379. PubMed ID: 32767484
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.
    Khatri S; Moore W; Gibson PG; Leigh R; Bourdin A; Maspero J; Barros M; Buhl R; Howarth P; Albers FC; Bradford ES; Gilson M; Price RG; Yancey SW; Ortega H
    J Allergy Clin Immunol; 2019 May; 143(5):1742-1751.e7. PubMed ID: 30359681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer.
    Reichman H; Itan M; Rozenberg P; Yarmolovski T; Brazowski E; Varol C; Gluck N; Shapira S; Arber N; Qimron U; Karo-Atar D; Lee JJ; Munitz A
    Cancer Immunol Res; 2019 Mar; 7(3):388-400. PubMed ID: 30665890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection.
    Kulaylat AS; Buonomo EL; Scully KW; Hollenbeak CS; Cook H; Petri WA; Stewart DB
    JAMA Surg; 2018 Dec; 153(12):1127-1133. PubMed ID: 30208386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophils: Old Players in a New Game.
    Sastre B; Rodrigo-Muñoz JM; Garcia-Sanchez DA; Cañas JA; Del Pozo V
    J Investig Allergol Clin Immunol; 2018; 28(5):289-304. PubMed ID: 30059011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils.
    Zheng X; Zhang N; Qian L; Wang X; Fan P; Kuai J; Lin S; Liu C; Jiang W; Qin S; Chen H; Huang Y
    Int J Cancer; 2020 Mar; 146(6):1730-1740. PubMed ID: 31840816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA.
    Moreira A; Erdmann M; Uslu U; Vass V; Schuler G; Schuler-Thurner B
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32121531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma.
    Kavanagh JE; d'Ancona G; Elstad M; Green L; Fernandes M; Thomson L; Roxas C; Dhariwal J; Nanzer AM; Kent BD; Jackson DJ
    Chest; 2020 Aug; 158(2):491-500. PubMed ID: 32275980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophils in the Tumor Microenvironment.
    Mattei F; Andreone S; Marone G; Gambardella AR; Loffredo S; Varricchi G; Schiavoni G
    Adv Exp Med Biol; 2020; 1273():1-28. PubMed ID: 33119873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer.
    Holub K; Biete A
    BMC Cancer; 2018 Dec; 18(1):1280. PubMed ID: 30577833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.